Multimodal liquid biopsy for early monitoring and outcome prediction of chemotherapy in metastatic breast cancer

Circulating tumor cells (CTCs) and circulating tumor DNA (ctDNA) are two cancer-derived blood biomarkers that inform on patient prognosis and treatment efficacy in breast cancer. We prospectively evaluated the clinical validity of quantifying both CTCs (CellSearch) and ctDNA (targeted next-generatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Bortolini Silveira, Amanda, Bidard, François-Clément, Tanguy, Marie-Laure, Girard, Elodie, Trédan, Olivier, Dubot, Coraline, Jacot, William, Goncalves, Anthony, Debled, Marc, Levy, Christelle, Ferrero, Jean-Marc, Jouannaud, Christelle, Rios, Maria, Mouret-Reynier, Marie-Ange, Dalenc, Florence, Hego, Caroline, Rampanou, Aurore, Albaud, Benoit, Baulande, Sylvain, Berger, Frédérique, Lemonnier, Jérôme, Renault, Shufang, Desmoulins, Isabelle, Proudhon, Charlotte, Pierga, Jean-Yves
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8429692/
https://www.ncbi.nlm.nih.gov/pubmed/34504096
http://dx.doi.org/10.1038/s41523-021-00319-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8429692/
https://www.ncbi.nlm.nih.gov/pubmed/34504096
http://dx.doi.org/10.1038/s41523-021-00319-4

Ejemplares similares